Press Release Nov 05 2025
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report for its SEZ II manufacturing facility in Ahmedabad. The report follows a USFDA inspection that took place in August and concluded with no observations, classifying the facility as No Action Indicated. This disclosure is made in accordance with regulatory requirements to inform investors and exchange members.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Nov 04 2025
- Press Release Oct 29 2025
- Press Release Oct 24 2025
- Press Release Oct 06 2025
- Press Release Oct 01 2025
Later from Zydus Lifesciences
- Press Release Nov 06 2025
- Press Release Nov 07 2025
- Zydus Lifesciences Limited Press Release Nov 11 2025
- Press Release Nov 13 2025
- Press Release Nov 14 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences